Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (33157)	12/13/2009 6:59:39 PM
From: DewDiligence_on_SI	1 Recommendation Read Replies (1) \| Respond to of 52153

…there are generic drugs, such as paroxitene (Paxil), which have been used (off label) for a long time to treat P.E., and they often work fairly well.< I would think any SSRI ought to work in this indication.

To: Brander who wrote (33157)	12/14/2009 4:51:12 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 52153

Brad, Concerning the issue of PE, I'm not speaking as the voice of experience on the subject (:>), as I fall more into the Willie Nelson category (:<). (For those that don't get the joke, twas one of Willie's more thought provoking admissions) But it appears that the drug companies are trying to build a market for their drug, when in reality all they are doing is taking two generic drugs and will charge huge amounts to cover their marketing efforts. Couldn't these two ingredient be compounded without any problems?